These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome? Sexton DJ Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129 [No Abstract] [Full Text] [Related]
6. Renin-angiotensin-aldosterone system inhibitors in heart failure. Shearer F; Lang CC; Struthers AD Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors in heart failure. Borek M; Charlap S; Frishman WH Med Clin North Am; 1989 Mar; 73(2):315-38. PubMed ID: 2645479 [TBL] [Abstract][Full Text] [Related]
8. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159 [TBL] [Abstract][Full Text] [Related]
9. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease]. Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316 [No Abstract] [Full Text] [Related]
10. Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failure. Kawano H; Node K Hypertens Res; 2010 Mar; 33(3):192-3. PubMed ID: 20203682 [No Abstract] [Full Text] [Related]
11. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists]. Sanada S; Kitakaze M Nihon Rinsho; 2003 May; 61(5):821-6. PubMed ID: 12755009 [TBL] [Abstract][Full Text] [Related]
12. Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention. Bernal J; Pitta SR; Thatai D Am J Cardiovasc Drugs; 2006; 6(6):373-81. PubMed ID: 17192127 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of heart failure: neurohormonal agents. Moser DK Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275 [TBL] [Abstract][Full Text] [Related]
14. [Peripheral and cardiac adaptive mechanisms in heart failure: the role of the renin-angiotensin system and its inhibition]. Drexler H Verh Dtsch Ges Inn Med; 1991; 97():552-7. PubMed ID: 1808945 [No Abstract] [Full Text] [Related]
15. Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure? Ogihara T; Rakugi H J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):184-5. PubMed ID: 18957391 [No Abstract] [Full Text] [Related]
16. The renin-angiotensin-aldosterone system and heart failure. Sayer G; Bhat G Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576 [TBL] [Abstract][Full Text] [Related]
18. [Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure]. Adamska-Dyniewska H Pol Arch Med Wewn; 1992; 88(2-3):165-70. PubMed ID: 1337204 [No Abstract] [Full Text] [Related]
19. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934 [TBL] [Abstract][Full Text] [Related]
20. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure. Davie AP; Rumley A; Lowe GD; McMurray JJ Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334 [No Abstract] [Full Text] [Related] [Next] [New Search]